Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 May;7(5):e655-e663.
doi: 10.1016/S2214-109X(19)30075-0. Epub 2019 Mar 22.

A multifaceted intervention to improve syphilis screening and treatment in pregnant women in Kinshasa, Democratic Republic of the Congo and in Lusaka, Zambia: a cluster randomised controlled trial

Affiliations
Randomized Controlled Trial

A multifaceted intervention to improve syphilis screening and treatment in pregnant women in Kinshasa, Democratic Republic of the Congo and in Lusaka, Zambia: a cluster randomised controlled trial

Fernando Althabe et al. Lancet Glob Health. 2019 May.

Abstract

Background: Despite international recommendations, coverage of syphilis testing in pregnant women and treatment of those found seropositive remains limited in sub-Saharan Africa. We assessed whether combining the provision of supplies with a behavioural intervention was more effective than providing supplies only, to improve syphilis screening and treatment during antenatal care.

Methods: In this 18-month, cluster randomised controlled trial, we randomly assigned (1:1) 26 urban antenatal care clinics in Kinshasa, Democratic Republic of the Congo, and Lusaka, Zambia, to receive a behavioural intervention (opinion leader selection, academic detailing visits, reminders, audits and feedback, and supportive supervision) plus supplies for syphilis testing and treatment (intervention group) or to receive supplies only (control group). The primary outcomes were proportion of pregnant women who had syphilis screening out of the total who attended the clinic; and the proportion of women who had treatment with benzathine benzylpenicillin out of those who tested positive for syphilis at their first antenatal care visit. This trial is registered at ClinicalTrials.gov, number NCT02353117.

Findings: The 18-month study period was Feb 1, 2016, to July 14, 2017. 18 357 women were enrolled at the 13 intervention clinics and 17 679 women were enrolled at the 13 control clinics at their first antenatal care visit. Syphilis screening was done in a median of 99·9% (IQR 99·0-100·0) of women in the intervention clinics and 93·8% (85·0-98·9) in the control clinics (absolute difference 6·1% [95% CI 1·1-14·1]; p=0·00092). Syphilis treatment at the first visit was done in a median of 100% (IQR 99·7-100·0) of seropositive women in intervention clinics and 43·2% (2·6-83·2) of seropositive women in control clinics (absolute difference 56·8% [12·8-99·0]; p=0·0028).

Interpretation: A behavioural intervention, together with the provision of supplies, can lead to more than 95% of women being screened and treated for syphilis. The sole provision of supplies is sufficient to reach such levels of screening coverage but is not sufficient to ensure high levels of treatment.

Funding: Bill & Melinda Gates Foundation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Trial profile
Figure 2
Figure 2
Syphilis screening and treatment across the clinics (A) Proportions of women screened at each of the 26 clinics. Numbers below bars are number of women screened over number of pregnant women attending clinic. (B) Proportions of women treated at the 23 clinics. Three clinics had no seropositive women, so proportion treated could not be calculated, and these clinics are not included on the graph. Numbers below bars are number of women treated over number of women who tested seropositive for syphilis.
Figure 3
Figure 3
Syphilis screening and treatment by study month Proportions of women screened of total number of pregnant women attending clinic (A) and proportions of women treated of total number of women who tested seropositive for syphilis (B) over the baseline and follow-up periods. The grey area indicates when the intervention was implemented, separating the baseline and post-intervention periods.

Comment in

References

    1. Gomez GB, Kamb ML, Newman LM, Mark J, Broutet N, Hawkes SJ. Untreated maternal syphilis and adverse outcomes of pregnancy: a systematic review and meta-analysis. Bull World Health Organ. 2013;91:217–226. - PMC - PubMed
    1. De Santis M, De Luca C, Mappa I. Syphilis infection during pregnancy: fetal risks and clinical management. Infect Dis Obstet Gynecol. 2012;2012:430585. - PMC - PubMed
    1. Wijesooriya NS, Rochat RW, Kamb ML. Global burden of maternal and congenital syphilis in 2008 and 2012: a health systems modelling study. Lancet Glob Health. 2016;4:e525–e533. - PMC - PubMed
    1. WHO . second edition. World Health Organization; Geneva: 2017. Global guidance on criteria and processes for validation: elimination of mother-to-child transmission of HIV and syphilis.http://apps.who.int/iris/bitstream/handle/10665/259517/9789241513272-eng...
    1. WHO . World Health Organization; Geneva: 2017. WHO guideline on syphilis screening and treatment for pregnant women.http://apps.who.int/iris/bitstream/10665/259003/1/9789241550093-eng.pdf - PubMed

Publication types

Substances

Associated data